These results were somewhat surprising since BMI1 is a well-known oncogene that is frequently overexpressed in human tumors including cervical carcinomas [50,51,52,53], and it has even been suggested that BMI1 autoantibodies may be useful as a biomarker of cervical carcinomas [54]. This evidence concerns the gene BMI1 and cervical carcinoma.